News

September 15, 2009 โ€“ EVEREST registry clinical results of the MitraClip therapy for patients with mitral regurgitation (MR) will be a big topic of discussion at the Transcatheter Cardiovascular Therapeutics (TCT) Conference Sept. 21-25 in San Francisco.

Home September 16, 2009
Home
News

September 16, 2009 โ€“ MemorialCare Heart and Vascular Institute at Long Beach Memorial Medical Center (LBMMC) in Long Beach, Calif., said it implanted a new, heart attack detection device in two heart attack survivors yesterday.

Home September 16, 2009
Home
Technology

September 16, 2009 โ€“ Hansen Medical Inc. today said it received FDA clearance for its next generation Sensei X Robotic Catheter System and it introduced the Artisan Extend Control Catheter. The company also plans to introduce the Lynx Robotic Ablation Catheter, a small, flexible irrigated ablation catheter, for customers in Europe this fall.

Home September 16, 2009
Home
News

September 15, 2009 โ€“ Tryton Medical Inc. said today its Tryton Side Branch Stent has been used in 250 procedures to treat atherosclerotic lesions at bifurcations in patients with heart disease.

Home September 15, 2009
Home
News

September 15, 2009 โ€“ Bracco is hosting a breakfast symposium at TCT 2009, โ€œEvidence-Based Selection of Contrast Media in Interventional Cardiology,โ€ for interventional cardiologists, cardiologists, nurses and technologists, informing them of the latest clinical evidence for contrast-induced nephropathy, including risk factors and best treatment options.

Home September 15, 2009
Home
Technology

September 15, 2009 โ€“ Spacelabs Healthcare today announced the U.S. launch of Sentinel, a sophisticated cardiology information management systems (CIMS), which facilitates analysis and reporting while also improving efficiency and eliminating errors.

Home September 15, 2009
Home
Feature

September 15, 2009 โ€“ Fluid monitoring with OptiVol Fluid Status Monitoring is a more accurate predictor of worsening heart failure compared to daily weight monitoring in heart failure patients with implantable devices, according to results released yesterday from the FAST (Fluid Accumulation Status Trial) clinical trial.

Home September 15, 2009
Home
Technology

September 15, 2009 โ€“ St. Jude Medical Inc. said yesterday the U.S. Food and Drug Administration (FDA) cleared and U.S. launch of the EnSite Velocity Cardiac Mapping System, which is designed to help physicians more efficiently diagnose and guide therapy to treat abnormal heart rhythms.

Home September 15, 2009
Home
News

September 15, 2009 - Positron Corp. announced that the Ministry of Health and Long Term Care of Ontario, Canada is making positron emission tomography (PET) scanning a publicly insured health service available to cancer and cardiac patients under conditions where PET scans have been proven to be clinically effective.

Home September 15, 2009
Home
Feature

September 9, 2009 - Integrated backscatter (IBS) images were acquired with transesophageal echocardiography (TEE) and 3-dimensional image reconstruction to identify an increase in atrial degeneration that might predict the occurrence of atrial fibrillation (AF) before left atrium (LA) dilation.

Home September 14, 2009
Home
News

September 14, 2009 โ€“ The 13th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) today featured four late breaking clinical trials at the Hynes Convention Center in Boston.

Home September 14, 2009
Home
News

September 13, 2009 โ€“ Mayo Clinic researchers say that "teachable software" designed to mimic the human brain may help them diagnose cardiac infections without an invasive exam, according to findings being presented today at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco.

Home September 14, 2009
Home
News

September 14, 2009 โ€“ OrbusNeich's Genous Bio-engineered R stent is feasible and safe in patients who need coronary revascularization before undeferrable noncardiac surgery and have to discontinue dual anti-platelet therapy, according to a paper published online in the International Journal of Cardiology.

Home September 14, 2009
Home
News

Sept. 14, 2009 โ€“ Abbott said today the Chinese State Food and Drug Administration (SFDA) has approved the XIENCE V Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease (CAD) โ€“ the leading cause of death in China.

Home September 14, 2009
Home
News

September 14, 2009 โ€“ InfraReDx said it will highlight its LipiScan Coronary Imaging System at the Cardiovascular Research Foundation's (CRF) annual Transcatheter Cardiovascular Therapeutics (TCT) scientific meeting, Sept. 21-25 in San Francisco. The LipiScan will be displayed in the emerging technologies section at booth 2410. InfraReDx events at TCT 2009 include:

Home September 14, 2009
Home
Subscribe Now